Natus Medical Inc. (BABY) Insider James B. Hawkins Purchases 10,000 Shares of Stock
Natus Medical Inc. (NASDAQ:BABY) insider James B. Hawkins purchased 10,000 shares of the company’s stock in a transaction on Wednesday, September 28th. The stock was acquired at an average cost of $38.48 per share, for a total transaction of $384,800.00. Following the completion of the transaction, the insider now owns 459,725 shares in the company, valued at $17,690,218. The purchase was disclosed in a filing with the SEC, which is available at the SEC website.
Shares of Natus Medical Inc. (NASDAQ:BABY) opened at 39.89 on Thursday. The company has a market capitalization of $1.29 billion, a PE ratio of 34.39 and a beta of 0.85. The stock’s 50 day moving average price is $40.37 and its 200-day moving average price is $36.81. Natus Medical Inc. has a 52-week low of $29.54 and a 52-week high of $51.05.
Natus Medical (NASDAQ:BABY) last posted its quarterly earnings data on Wednesday, July 20th. The company reported $0.39 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.36 by $0.03. The business earned $96 million during the quarter, compared to the consensus estimate of $92.71 million. Natus Medical had a return on equity of 13.82% and a net margin of 10.20%. Natus Medical’s quarterly revenue was up 4.5% on a year-over-year basis. During the same period last year, the company earned $0.34 earnings per share. On average, analysts expect that Natus Medical Inc. will post $1.58 earnings per share for the current year.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Acrospire Investment Management LLC boosted its position in shares of Natus Medical by 39.1% in the second quarter. Acrospire Investment Management LLC now owns 2,844 shares of the company’s stock valued at $108,000 after buying an additional 800 shares during the period. BlackRock Inc. boosted its position in shares of Natus Medical by 36.0% in the second quarter. BlackRock Inc. now owns 3,096 shares of the company’s stock valued at $117,000 after buying an additional 820 shares during the period. Invictus RG bought a new position in shares of Natus Medical during the first quarter valued at approximately $148,000. PineBridge Investments L.P. boosted its position in shares of Natus Medical by 3.7% in the second quarter. PineBridge Investments L.P. now owns 4,200 shares of the company’s stock valued at $159,000 after buying an additional 149 shares during the period. Finally, Teacher Retirement System of Texas boosted its position in shares of Natus Medical by 13.9% in the second quarter. Teacher Retirement System of Texas now owns 4,602 shares of the company’s stock valued at $174,000 after buying an additional 562 shares during the period. Institutional investors and hedge funds own 87.92% of the company’s stock.
Several research analysts have commented on the company. Raymond James Financial Inc. raised Natus Medical from a “market perform” rating to an “outperform” rating and set a $46.00 price target on the stock in a research report on Tuesday, September 13th. Zacks Investment Research downgraded Natus Medical from a “buy” rating to a “hold” rating in a research report on Wednesday.
About Natus Medical
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Receive News & Stock Ratings for Natus Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Inc. and related stocks with our FREE daily email newsletter.